Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Merck Group
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Price fixing settlement === Generics UK (Merck's former British subsidiary, the global Generics business being sold on 2 October 2007) paid a Β£12M [[out-of-court settlement]] with the [[Department of Health and Social Care]] of the UK over involvement in an alleged [[Price fixing|price and supply fixing]] cartel.<ref>{{cite news | first= Simon| last= Bowers| title=Merck subsidiary pays Β£12m over price-fixing claims in sales to NHS | date= 30 June 2005| url =http://business.guardian.co.uk/story/0,3604,1517712,00.html | work =[[The Guardian]] | access-date = 11 October 2007 | location=London}}</ref> The [[National Health Service|NHS]] alleges various drugs companies exploited the [[Oligopoly|oligopolistic market]] conditions, forcing the NHS to pay inflated prices. NHS fraud investigators believe there was a [[Conspiracy (civil)|conspiracy]] to limit the supply of 30 of its most commonly prescribed drugs, including a class of [[penicillin]] [[antibiotics]] and to a [[generic drugs|generic]] version of best-selling [[Peptic ulcer|ulcer]] treatment [[Ranitidine|Zantac]].<ref>{{cite news | first= Sam| last= Lister| title=Drug chiefs on price-fixing charges | date= 6 April 2006| url =http://www.timesonline.co.uk/tol/news/uk/health/article702469.ece | archive-url =https://archive.today/20110524021422/http://www.timesonline.co.uk/tol/news/uk/health/article702469.ece | url-status =dead | archive-date =24 May 2011 | work =[[The Times]] | access-date = 11 October 2007 | location=London}}</ref> The NHS has so far filed claims in relation to just three drugs, seeking damages of more than Β£150m, while the [[Serious Fraud Office (United Kingdom)|Serious Fraud Office]] (SFO) is conducting a parallel investigation into the price-fixing allegations limited to the supply of blood-thinning pill [[warfarin]] and [[penicillin]]-based [[antibiotics]]. Homes and offices of [[Senior management|executives]] at six firms, including [[Ranbaxy]], Generics UK, [[Norton Healthcare]], Goldshield and Regent-GM were raided by the SFO in May 2002.{{cn|date=June 2024}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)